Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

12.01.2026

3 Am J Cardiol
1 Anesth Analg
2 Angiology
1 Arterioscler Thromb Vasc Biol
19 Catheter Cardiovasc Interv
1 Circ Cardiovasc Interv
1 Circulation
2 Crit Care Med
3 Eur Heart J
2 Int J Cardiol
6 J Am Coll Cardiol
1 J Mol Cell Cardiol
2 JAMA
1 Mayo Clin Proc
1 PLoS One
1 Thromb Haemost



    Am J Cardiol

  1. KIM M, Thakurathi P, Nagpal J, Satija V, et al
    Outcomes and Predictors of In-hospital Mortality in Nonagenarians with NSTEMI: A Comparison of PCI and Medical Management.
    Am J Cardiol. 2026;260:36-43.
    >> Share

  2. SIBY A, Hashemzadeh M, Movahed MR
    Higher mortality in male patients with Takotsubo cardiomyopathy appears to be related to higher complication rates.
    Am J Cardiol. 2025 Nov 25:S0002-9149(25)00698.
    >> Share

  3. GOEL R, Spirito A, Cao D, Sartori S, et al
    Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2026 Jan 5:S0002-9149(25)00744.
    >> Share


    Anesth Analg

  4. YANG Y, Wang L, Li C, Wang H, et al
    Early Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Acute Brain Injury and Mortality in Patients With Cardiogenic Shock.
    Anesth Analg. 2026;142:326-334.
    >> Share


    Angiology

  5. CHEN S, Li Y
    Letter: Association of SIRI With Severity of Coronary Artery Disease in Patients With Coronary Heart Disease: A CSCD-TCM Plus Study.
    Angiology. 2026 Jan 8:33197251415211. doi: 10.1177/00033197251415211.
    >> Share

  6. DEMIREL A, Engin M, Aydin U, Ata Y, et al
    Letter: Inflammatory Markers to Predict Carotid Artery Plaque in Patients With Coronary Artery Disease.
    Angiology. 2026 Jan 9:33197251415222. doi: 10.1177/00033197251415222.
    >> Share


    Arterioscler Thromb Vasc Biol

  7. WANG Z, Gan P
    Enhancer Dynamics for Gene Regulation in the Cardiovascular System.
    Arterioscler Thromb Vasc Biol. 2026 Jan 8. doi: 10.1161/ATVBAHA.125.323110.
    >> Share


    Catheter Cardiovasc Interv

  8. PUTRA BE, Tadano Y, Kaneko U, Sundarajoo M, et al
    A Simple Approach for 3D IVUS-Angiographic Co-Registration for CTOs Using the "Be-The-Wire" Cognitive Model.
    Catheter Cardiovasc Interv. 2025 Nov 24. doi: 10.1002/ccd.70371.
    >> Share

  9. ELBENY AM, Elkasaby MH, Fouad TA, Soltan ME, et al
    Drug-Coated Balloon Versus Drug-Eluting Stent for Large Coronary Arteries in Patients Presenting With STEMI: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2026;107:439-452.
    >> Share

  10. ZUBIAUR J, Galeote G, Jurado-Roman A, Fernandez-Portales J, et al
    Coronary Rotational ATherectomy Elective Versus Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure: Long-Term Outcomes of CRATER Trial.
    Catheter Cardiovasc Interv. 2026;107:431-438.
    >> Share

  11. CHNG ACC, Wong N, Chin CY
    High Risk Optical Coherence Tomography Findings in a Case of Coronary Perforation Following Orbital Atherectomy.
    Catheter Cardiovasc Interv. 2026;107:428-430.
    >> Share

  12. JI B, Lai Y, Liu XB, Xie Y, et al
    Aortic Root Dissection Masquerading as Acute Coronary Syndrome: The Critical Role of Intravascular Ultrasound.
    Catheter Cardiovasc Interv. 2025 Nov 20. doi: 10.1002/ccd.70352.
    >> Share

  13. SANDOVAL Y, Carvalho P, Cheng V, Cavalcante J, et al
    Artificial Intelligence Enhanced Analysis of Coronary CT Angiography to Facilitate Chronic Total Occlusion Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2025 Nov 20. doi: 10.1002/ccd.70312.
    >> Share

  14. SAHOO SK, Barik R, Sathia S, Mohanty CR, et al
    Challenges of Coronary Access in Acute Coronary Syndrome With Severe Peripheral Arterial Disease: A Fatal Case.
    Catheter Cardiovasc Interv. 2026;107:387-390.
    >> Share

  15. BAI X, Gao H, Lv Y, Sun D, et al
    Impact of Chronic Kidney Disease on Outcomes With Drug-Coated Balloons Versus Drug-Eluting Stents: Insights From the REC-CAGEFREE I Trial.
    Catheter Cardiovasc Interv. 2026;107:304-314.
    >> Share

  16. COLOMBO A, Carbonaro D, Zhang M, Shen C, et al
    Are Ultrathin Stents Optimal for Bifurcation Lesions? Insights From Computational Modeling of Provisional and DK-Crush Techniques.
    Catheter Cardiovasc Interv. 2026;107:258-272.
    >> Share

  17. DZIEWIERZ A, Rzeszutko L, Niewiara L, Legutko J, et al
    Sex-Based Differences in Coronary Physiological Assessment in Patients With Severe Aortic Stenosis.
    Catheter Cardiovasc Interv. 2025 Nov 9. doi: 10.1002/ccd.70303.
    >> Share

  18. ERI RR, Zahrani S, Andriono P, Silalahi TDA, et al
    Immediate and Midterm Efficacy and Safety of Intravascular Lithotripsy for Calcified In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2026;107:173-186.
    >> Share

  19. ELSAWAH AM, Elhadainy MS
    Balloon Over-the-Wire Opposing Support (BOOST) Technique: The Sawah-Sabry Approach for Retrieval of a Stuck Retrograde Microcatheter in Chronic Total Occlusion PCI-A Case Report.
    Catheter Cardiovasc Interv. 2026;107:165-170.
    >> Share

  20. GALO J, Maksoud A, Shah S, Toleva O, et al
    Predictors of Variability in Coronary Flow Reserve and Microvascular Resistance Measurement Using the Bolus Thermodilution Technique.
    Catheter Cardiovasc Interv. 2026;107:153-161.
    >> Share

  21. HONDA T, Kawano H, Akashi R, Koga S, et al
    Nutrition Status May be Related to Discordance of the Resting Full-Cycle Ratio and Fractional Flow Reserve.
    Catheter Cardiovasc Interv. 2026;107:114-123.
    >> Share

  22. LI GB, Zhu DQ, Ouyang SM
    Development and Internal Validation of a Four-Predictor Nomogram for In-Stent Restenosis After Drug-Eluting Stent Implantation in Patients With Overweight/Obesity.
    Catheter Cardiovasc Interv. 2026;107:103-111.
    >> Share

  23. YAO Z, Zhou Y, Yin J, Wu Y, et al
    A Novel Propyl Gallate-Based Paclitaxel-Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions.
    Catheter Cardiovasc Interv. 2026;107:91-100.
    >> Share

  24. FAN C, Zou Y, Chen L, Wang Y, et al
    Intra-Aortic Balloon Pump Use in Acute Coronary Syndrome Without Cardiogenic Shock: Association With Mortality in the CCC-ACS Cohort.
    Catheter Cardiovasc Interv. 2025 Oct 28. doi: 10.1002/ccd.70257.
    >> Share

  25. FUJIMURA T, Okamura T, Miyazaki Y, Akase H, et al
    Optimization of a Double-Kissing Culotte Stenting Using Three-Dimensional Optical Frequency Domain Imaging for Left Main Coronary Bifurcation Lesions: A Bench Model Analysis.
    Catheter Cardiovasc Interv. 2025 Oct 28. doi: 10.1002/ccd.70286.
    >> Share

  26. CORBALLIS N, Merinopoulos I, Bhalraam U, Gunawardena T, et al
    A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions.
    Catheter Cardiovasc Interv. 2026;107:3-14.
    >> Share


    Circ Cardiovasc Interv

  27. BRUCE CG, Babaliaros VC, Paone G, Gleason PT, et al
    Percutaneous Aorto-Coronary Bypass Graft to Prevent Coronary Obstruction Following TAVR: First Human VECTOR Procedure.
    Circ Cardiovasc Interv. 2026 Jan 6:e016130.
    >> Share


    Circulation

  28. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    >> Share


    Crit Care Med

  29. PARLOW S, Jung RG, Almoosawy SA, Lepage-Ratte MF, et al
    Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Crit Care Med. 2026 Jan 8. doi: 10.1097/CCM.0000000000007013.
    >> Share

  30. NG GWY, Low CJW, Ng KJ, Ling RR, et al
    Predictive Models for Mortality in Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Crit Care Med. 2026;54:142-153.
    >> Share


    Eur Heart J

  31. SANIDAS E, Michalopoulou H, Thomopoulos C
    Beta-blockers in post-myocardial infarction patients: refractive errors in reading the evidence.
    Eur Heart J. 2026 Jan 6:ehaf1053. doi: 10.1093/eurheartj/ehaf1053.
    >> Share

  32. GVOZDEVA A, Zakiev V, Ushakova O
    The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.
    Eur Heart J. 2026 Jan 6:ehaf1052. doi: 10.1093/eurheartj/ehaf1052.
    >> Share

  33. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.
    Eur Heart J. 2026 Jan 6:ehaf924. doi: 10.1093.
    >> Share


    Int J Cardiol

  34. VON OSMANSKI BI, Ankarfeldt MZ, Olsen NT, Mouridsen MR, et al
    Ten clinically important subgroups of myocardial infarction survivors: Identification by latent class analysis.
    Int J Cardiol. 2026 Jan 6:134139. doi: 10.1016/j.ijcard.2025.134139.
    >> Share

  35. HONDA S, Noguchi T
    A step back in time, or a call to action? Revisiting cardiology-unit access in modern acute myocardial infarction treatment.
    Int J Cardiol. 2026 Jan 6:134144. doi: 10.1016/j.ijcard.2025.134144.
    >> Share


    J Am Coll Cardiol

  36. HUSSAIN SM, Bjurling J, Yu C, Tonkin AM, et al
    Loss of Y Chromosome and Major Cardiovascular Events in a Prospective Study of Older Men.
    J Am Coll Cardiol. 2026;87:36-45.
    >> Share

  37. ABUSHAMAT LA, Hamid A, Nambi V, Wu H, et al
    Reducing Cardiovascular Disease Risk in Obesity: An Unexpected But Welcome FOURIER Transformation.
    J Am Coll Cardiol. 2026 Jan 7:S0735-1097(25)10258.
    >> Share

  38. HONIGBERG MC
    CHIP, LOY, and Other Clonal Hematopoiesis Subtypes in Cardiovascular Disease.
    J Am Coll Cardiol. 2026;87:49-51.
    >> Share

  39. LIBBY P, Nordan T, Chiu N, Oren O, et al
    Wondering Y: How Might Loss of the Y Chromosome Promote Cardiovascular Disease in Aging Men?
    J Am Coll Cardiol. 2026;87:46-48.
    >> Share

  40. KRUMHOLZ HM
    Older Patients and Cardiovascular Disease: At the Center of Care, on the Margins of Science.
    J Am Coll Cardiol. 2026;87:1-3.
    >> Share

  41. MARTI-CASTELLOTE PM, Badrouchi S, Claggett B, Xu D, et al
    Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
    J Am Coll Cardiol. 2025 Nov 9:S0735-1097(25)10066.
    >> Share


    J Mol Cell Cardiol

  42. GUMZ ML, Eikenberry SA
    Watching the clock: Blood pressure and cardiovascular disease influence circadian machinery in pre-clinical models.
    J Mol Cell Cardiol. 2026 Jan 2:S0022-2828(25)00236.
    >> Share


    JAMA

  43. COMBES A, Saura O, Nesseler N, Lebbah S, et al
    Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.
    JAMA. 2026;335:60-69.
    >> Share

  44. KOUGIAS P, Sharath SE, Zhan M, Carson JL, et al
    Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial.
    JAMA. 2025 Nov 8:e2520841. doi: 10.1001/jama.2025.20841.
    >> Share


    Mayo Clin Proc

  45. PRASAD VK, Ogbonnaya C, Oh H, Atkin A, et al
    Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled Cohort.
    Mayo Clin Proc. 2026 Jan 5:S0025-6196(25)00573.
    >> Share


    PLoS One

  46. XU X, Cai L, Dang X, Han J, et al
    Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-kappaB signaling pathway.
    PLoS One. 2026;21:e0340382.
    >> Share


    Thromb Haemost

  47. HONDA S, Cho KH, Lee SY, Takegami M, et al
    Prognostic Value of BARC-defined Bleeding in East Asian Acute Myocardial Infarction Patients: Evidence from Multicentre Registries in Korea and Japan.
    Thromb Haemost. 2026 Jan 6. doi: 10.1055/a-2773-5644.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016